These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 16528824)

  • 41. The history and future of food fortification in the United States: a public health perspective.
    Backstrand JR
    Nutr Rev; 2002 Jan; 60(1):15-26. PubMed ID: 11842999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Jere Goyan, only pharmacist to lead FDA, dies at 76.
    Traynor K
    Am J Health Syst Pharm; 2007 Mar; 64(5):459. PubMed ID: 17322156
    [No Abstract]   [Full Text] [Related]  

  • 43. [History of the development of US legislation to drugs].
    Utkin OB
    Farmatsiia; 1977; 26(4):78-82. PubMed ID: 332534
    [No Abstract]   [Full Text] [Related]  

  • 44. Historical perspectives on regulatory issues of antimicrobial resistance.
    Gustafson RH
    Vet Hum Toxicol; 1993; 35 Suppl 1():2-5. PubMed ID: 8236753
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation].
    Maio G
    Dtsch Med Wochenschr; 2001 Oct; 126(42):1183-6. PubMed ID: 11607860
    [No Abstract]   [Full Text] [Related]  

  • 46. Meat! It is what you do not know that hurts you: why FDA should reevaluate the use of carbon monoxide in modified atmospheric meat packaging.
    Bailey NJ
    Food Drug Law J; 2008; 63(4):735-51. PubMed ID: 19593921
    [No Abstract]   [Full Text] [Related]  

  • 47. Proposed new legislation on food labeling and nutrition.
    Hutt PB; Sloan AE
    ASDC J Dent Child; 1980; 47(2):141-3. PubMed ID: 6988477
    [No Abstract]   [Full Text] [Related]  

  • 48. Reading our lips: the history of lipstick regulation in Western seats of power.
    Schaffer SE
    Food Drug Law J; 2007; 62(1):165-225. PubMed ID: 17444030
    [No Abstract]   [Full Text] [Related]  

  • 49. Regulating Homeopathic Products - A Century of Dilute Interest.
    Podolsky SH; Kesselheim AS
    N Engl J Med; 2016 Jan; 374(3):201-3. PubMed ID: 26789866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 51. Vioxx's history and the need for better procedures and better testing.
    Gilhooley M
    Seton Hall Law Rev; 2007; 37(4):941-68. PubMed ID: 18363218
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
    Binder GM
    Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 54. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.
    Public Affairs Committee of the Teratology Society
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):627-30. PubMed ID: 17663419
    [No Abstract]   [Full Text] [Related]  

  • 55. Investigations and reports respecting FDA regulation of new drugs (Part I).
    Hutt PB
    Clin Pharmacol Ther; 1983 Apr; 33(4):537-48. PubMed ID: 6339149
    [No Abstract]   [Full Text] [Related]  

  • 56. The AVMA legislative initiative.
    Kram MA
    J Am Vet Med Assoc; 1993 May; 202(10):1668-70;discussion 1684-92. PubMed ID: 8514579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 58. Healthy public relations: the FDA's 1930s legislative campaign.
    Kay G
    Bull Hist Med; 2001; 75(3):446-87. PubMed ID: 11568487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigations and reports respecting FDA regulation of new drugs (Part II).
    Hutt PB
    Clin Pharmacol Ther; 1983 May; 33(5):674-87. PubMed ID: 6340910
    [No Abstract]   [Full Text] [Related]  

  • 60. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.